Inspire Medical Systems (INSP) Equity Average (2018 - 2026)

Inspire Medical Systems' Equity Average history runs 9 years deep, the most recent figure standing at $786.8 million for Q1 2026.

• In Q1 2026, Equity Average rose 18.72% year-over-year to $786.8 million; the TTM figure through Mar 2026 stood at $786.8 million (up 18.72% YoY), while the FY2025 annual figure was $735.4 million, up 16.53% from the prior year.
• Equity Average came in at $786.8 million for Q1 2026 at Inspire Medical Systems, up from $723.8 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $786.8 million in Q1 2026 to a low of $226.0 million in Q2 2022.
• A 5-year average of $556.1 million and a median of $580.8 million in 2024 frame the typical range for Equity Average.
• Across the five-year window, Equity Average rose 0.27% in 2022 and jumped 128.74% in 2023, its largest moves.
• Inspire Medical Systems' Equity Average stood at $483.1 million in 2022, then gained by 15.57% to $558.3 million in 2023, then gained by 24.14% to $693.1 million in 2024, then rose by 4.43% to $723.8 million in 2025, then climbed by 8.7% to $786.8 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $786.8 million, $723.8 million, and $672.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison